Review Article

[Retracted] Efficacy of Cold Atmospheric Plasma Therapy on Chronic Wounds: An Updated Systematic Review and Meta-Analysis of RCTs

Table 1

General characteristics of the included studies.
(a)

Author1 yearDesignCountrySample size (E/C)Age (range or )Type of woundIntervention groupCAP technical parametersControl groupOutcomesTreatment endpoints or treatment duration

Quantitative analysis
Isbary15
2010
RCTGermany38/3840–94yVU, AU, DFU, TU5 min of CAP every day and STMicrowave 2.46 GHz,86 W; Ar2.2 slm; distance to torch 2 cmSTNegative bacterial swabs
or the wound was healed, or the patient decided to stop.
Isbary16
2012
RCTGermanyα: 14/14
β: 10/10
40–85yAU, VU,
TU
2 min of CAP every day and STMicrowave 2.46 GHz; voltage 50–100 V; power 86 W; Ar2.2 slmSTNegative bacterial swabs
or the wound was healed, or the patient decided to stop.
Heinlin17
2013
RCTGermany34/34Skin graft donor site healing2 min of CAP every day and STMicrowave 2.45 GHz, 86 W; Ar2.2 slm; distance to torch 2 cmPlacebo and STComplete healing of the donor site or the patient decided to stop.
Mirpour22
2020
RCTTehran22/22E:
C:
DFUCAP (3 times a week for 3 weeks) and STHelium gas; voltage 10 kV;
frequency 6 kHz
ST① ③3 weeks
Moelleken19
2020
RCTGermanyE1: 14
E2: 13
C: 10
E1: avg65.2y
E2: avg66.8y
C: avg73.7y
VU, DFU, pyoderma gangrenosumE1: CAP (1 time a week for 12 weeks) and ST
E2: CAP (3 times a week for 12 weeks) and ST
ArPlacebo and ST① ④12 weeks
Amini21
2020
RCTTehran22/2218–80yDFUCAP(3 times a week for 3 weeks)and STHelium gas; voltage 10 kV;
Frequency 6 kHz
ST②⑤3weeks
Samsavar23
2021
RCTTehran10/10E:
C:
DFUCAP (2 times a week for 6 weeks) and STHelium gas; voltage 4.5 Kv; frequency 22 kHzST6weeks

(b)

Author1
year
DesignCountrySample size (E/C)Age
(range or
)
Type of woundIntervention groupCAP technical parametersControl groupOutcomesTreatment duration

Strohal24
2022
RCTAustria39/39E: 42.58–93.91y
C: 42.58–93.91y
VLU, DFU3 times in the 1st week, twice in the 2nd week, and once per week in the following observation periodCAP-jet treatment (kINPen® med, neoplas med GmbH, Greifswald/Germany)Best practice wound dressings6 weeks
Quantitative analysis
Brehmer18
2014
RCTGermany7/7E: 51–85y
C: 51–83y
VLUCAP (3 times per week for 8 weeks) and STFrequency 50 Hz, maximum power consumption: 8 VAST① ④8 weeks
Chuangsuwanich20
2016
RCTThailand23/19E:
C:
PUCAP (once per week for 8 weeks) and STAr; frequency 15–20 Hz; peak voltage was around 6 to 7 kVSTWound and bacterial load reduction is assessed by scores8 weeks
Stratman12
2020
RCTGermany33/32E:
C:
DFUCAP (8 times within 2 weeks) and STArSTWound and bacterial load reduction is assessed by scores2 weeks
Van Welzen13
2021
RCTGermany10/10Skin graft donor site healingCAP (3 times for 1 week) and STCAP was applied using a single dose of 100–240 V and 1.3–8 VAST1 week
Hiller14
2022
RCTGermany14/13E:
C:
DFUCAP (8 times within 2 weeks) and STArPlacebo and STInflammatory cytokines

Abbreviations: CAP: cold atmospheric plasma; RCT: randomized clinical trials; E-CAP group; C: control group; y-years; ST: standard treatment; Ar: argon gas; DFU: diabetic foot ulcer; VLU: venous leg ulcer; VU: venous ulcer; AU: arterial ulcer; PU: pressure ulcer; TU: traumatic ulcer. Outcomes: (a) reduction of wound area (cm2); (b) immediate reduction of the bacterial load (log Nfc/Nic, where Nfc/Nic is the number of colonies after (before) each treatment; (c) long-term reduction of the bacterial load (log Nfc/Nic, where Nfc/Nic is the number of colonies after (before) the entire treatment duration); (d) assessment of pain (visual analogue scale (VAS) from 0 (no pain) to 10 (most severe pain)); (e) the level of inflammatory cytokine.